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ABSTRACT 
The present study involves in the evaluation of starch xanthate as a superdintegrant in the formulation of fast dissolving tablets of poorly soluble 
drugs employing 23factorial design. By using gelatinization process starch xanthate was synthesized. Then the synthesized starch xanthate was 
evaluated under physical and micromeritic methods. To develop starch xanthate as a superdisintegrant, fast dissolving tablet of aceclofenac was 
prepared by direct compression method employing starch xanthate in different proportions in each case employing 23 factorial design. All the 
prepared fast dissolving tablets were evaluated for drug content, hardness, friability, disintegration time and other dissolution characteristics 
like PD10, DE5 and K1. The prepared starch xanthate was found to be fine, free flowing slightly crystalline powder. Starch xanthate shown good 
swelling in water. The swelling index was 50% and all micrometric properties shown good flow and compressibility needed for solid dosage 
from manufacturing. All the formulated fast dissolving tablets employing starch xanthate were of good quality with regard to drug content, 
hardness and friability and fulfilled the official (IP/USP) requirements of compressed tablets with regard to the above mentioned physical 
properties. Starch xanthate was found to be a superdisintegrant which enhanced the dissolution efficiency when combined with croscarmellose 
sodium, with the aceclofenac and hence it could be utilized in the formulation of fast dissolving tablets to provide immediate release of the 
contained drug within 10 minutes. 
Keywords: Fast Dissolving, Superdisintegrant, Starch xanthate, Dissolution efficiency 
 
Article Info: Received 05 Feb 2019;     Review Completed 08 March 2019;     Accepted 09 March 2019;     Available online 15 March 2019 
Cite this article as: 
Santosh Kumar R, Satya Yagnesh TN, Optimisation of aceclofenac fast dissolving tablets employing starch xanthate using 23 
factorial design, Journal of Drug Delivery and Therapeutics. 2019; 9(2):222-230     
http://dx.doi.org/10.22270/jddt.v9i2.2556                                                         
*Address for Correspondence:  
R. Santosh Kumar, GITAM Institute of Pharmacy, GITAM (Deemed to be University), Rushikonda, Visakhapatnam, A.P 530045, India 
 
 
INTRODUCTION 
In total dosage forms, Oral routes of drug administration 
have wide acceptance up to 50-60%. In solid dosage forms, 
Fast dissolving tablets are containing indicated substances 
which disintegrate rapidly, usually within few seconds when 
placed upon tongue requiring additional water to facilitate 
swallowing. Fast dissolving tablets give great advantages for 
the patients having difficulty in swallowing. The elderly 
constitute a major portion of today’s population mainly 
because of increased life span of individuals. Physiological 
and neurological conditions, like dysphasia, a risk of choking, 
and hand tremors are leading causes of patient non-
compliance in the self-administration of conventional solid 
oral dosage forms 1. Fast dissolving tablets overcome this 
problem and provide the advantages for pediatrics, geriatric 
2-3, bedridden, disabled patients and also for who may have 
difficulty in swallowing tablets, capsules and liquid orals. 
FDT will rapidly disintegrate in the mouth without the need 
of water 4-5. Fast dissolving tablet formulation provides 
sufficient strength, quick disintegration/ dissolution in the 
mouth without water 6, rapid dissolution and absorption of 
the drug, which will produce the quick onset of action. Pre 
gastric absorption of FDT can result in improved 
bioavailability and as a consequence of reduced dose 7. 
Various techniques can be used to formulate fast dissolving 
tablets. Direct compression is one of the methods which 
require the administration of superdisintegrant or highly 
water soluble excipients into the formulation to achieve fast 
tablet disintegration. Direct compression does not need the 
use of water or heat during the formulation procedure and is 
the ideal method for moisture and heat-liable medication. 
The goal of the work was to formulate and characterize fast-
dissolving tablets of aceclofenac by utilizing optimization 
techniques for rapid dissolution of drug and absorption 
employing a new superdisintegrant i.e., starch xanthate. 
Optimization technique:  
Optimization technique give both a depth of understanding 
and an ability to explore and define ranges for formulation 
and processing factors with a rational approach to the 
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selection of various experimental and manufacturing step for 
a given product, to quantitatively select a formulation. It is at 
this point that optimization can become a useful tool to 
quantitative a formulation that has been qualitatively 
demonstrated. 
The current investigation deals with an attempt of 
systematic formulation approach for optimization of 
aceclofenac fast dissolving tablets employing starch 
xanthate, sodium starch glycolate, and croscarmellose 
sodium as superdisintegrants. A 23 factorial design was 
utilized to investigate the main and interaction effects of the 
three formulation variables i.e., starch xanthate (A), sodium 
starch glycolate (B), croscarmellose sodium (C) in each case 
to find the formula with less disintegration time and more 
dissolution efficiency 5 min and to permit arbitrary selection 
of tablets with immediate release of drug with in 5 min.  
MATERIALS AND METHODS 
Materials: 
Sodium hydroxide, Carbon disulphide, Lactose was 
purchased from Finar chemicals Ltd, Ahmedabad. Potato 
starch, Aceclofenac, Sodium starch glycolate, Croscarmellose 
sodium was obtained from Yarrow chem. Products, Mumbai.  
Microcrystalline cellulose was bought from Qualigens fine 
chemicals, Mumbai. Talc and Magnesium stearate was 
obtained from Molychem, Mumbai. 
Preparation of starch xanthate (a novel 
Superdisintegrant): 
At first, the potato starch of 35.4g was slurried in 225ml 
distilled water and 8g of sodium hydroxide was dissolved in 
distilled water. Both are stirred continuously for 30 minutes. 
To this 5ml of carbon disulphide was added and stirred for 
16hours at 250C.After 16 hours, it was filtered and washed 
with 75ml of distilled water, 500ml of acetone and 100ml of 
ether. The product was kept in oven at 600C for 2 hrs. The 
product obtained was ground and sieved.     
Characterization of starch xanthate: 
The starch xanthate prepared was evaluated for the 
following 
Solubility: 
The solubility of starch xanthate was evaluated in water, 
aqueous buffer of pH 1,2,3,4, and 6.196 and organic solvents 
such as alcohol, dichloromethane, chloroform, acetone and 
petroleum ether. 
pH: 
The pH of 1% w/v slurry was calculated by pH meter. 
Melting point: 
The melting point was measured by using melting point 
apparatus. 
Viscosity: 
The viscosity of 1% dispersion in water was determined 
using Ostwald viscometer. 
Swelling index: 
The starch xanthate (200 mg) was administered to 10 ml of 
water and light liquid paraffin taken in two Different 
graduated test tubes and mixed. For 12 h, the dispersion in 
the tubes was allowed to stand. The volumes of the sediment 
in the tubes were noted. The swelling index o the material 
was measured as follows.  
 
Test for gelling property:  
At 1000C, for 30 min the gelling property (gelatinization) of 
the starch and starch xanthate prepared was evaluated by 
heating a 7% w/v dispersion of each in water. 
Particle size: 
The particle size analysis was done by sieving using standard 
sieves. 
Density: 
The density (g/cc) was determined by liquid displacement 
method using benzene as liquid. 
Bulk density: 
Both loose bulk density (LBD) and tapped bulk density 
(TBD) were demonstrated by transferring the accurate 
weighed amount of sample in 50 ml measuring cylinder, the 
granules without any agglomerates and calculated the 
volume of packing and tapped 50 times on a plane surface 
and tapped volume of packing recorded and LBD and TBD 
calculated by following formula[8]. 
 
 
Percentage compressibility index  
The percentage compressibility of powder mix was 
determined by Carr’s Compressibility Index calculated by the 
following formula 9. 
 
Where, TBD= Tapped bulk density; LBD= Loose bulk density. 
Angle of repose 
The frictional forces in loose powder or granules can be 
determined by the angle of repose. This is the maximum 
angle possible between the surface of a mass of powder or 
granules and the horizontal plane. Angle of repose is 
determined by applying the next equation; 
                   
Where θ = angle of repose; h = height of pile; r = radius of 
pile. 
Fourier Transform Infrared (FTIR) Spectroscopy: 
The FTIR spectra of starch xanthate were recorded on 
samples prepared in potassium bromide (KBr) disks using a 
BRUKER FT –IR, (Tokyo, Japan). Samples were prepared in 
(KBr) disks by means of a hydrostatic press at 6-8 tons 
pressure. The scanning range was 500 to 4000 cm-1. 
X – Ray diffraction:  
The diffraction pattern of starch xanthate was recorded with 
an x-ray diffractometer (analytical spectra’s Pvt. Ltd., 
Singapore). X-ray diffraction was performed at room 
temperature (300C) with a diffractometer; target, Cu(λ1.54 
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A), filter, Ni; voltage,40 ⱪV; current 30mA; time constant 
10mm/s ; scanning rate 20/min; measured from 2.5-500 at 
full scale 200. 
Drug – excipients compatibility studies: 
The compatibility of starch xanthate with the selected drug 
(Aceclofenac) was evaluated in DSC and FTIR studies. 
Differential scanning calorimetry (DSC): 
 The DSC thermograms of aceclofenac, and their mixtures (1: 
1) with starch xanthate were recorded on Perkin Elmer 
thermal analyser samples (2- 5 mg) were sealed into 
aluminium pans and scanned at a heating rate of 100C min-1 
over a temperature range 30 – 3500C. 
Infrared spectroscopy:  
The Fourier transform infra red (FTIR) spectra of 
aceclofenac, and their mixtures (1: 1) with starch xanthate 
were recorded on a Perkin Elmer, IR Spectrophotometer 
model: Spectrum RXI, using KBr disc as reference. 
 
Preparation of aceclofenac fast dissolving tablets:   
By direct compression method, the tablets were prepared 
employing 23 factorial design in which 3 independent 
variables {superdisintegrants i.e., starch xanthate (A), 
sodium starch glycolate (B), croscarmellose sodium (C)} and 
1 dependent variable (dissolution efficiency in 5 min) were 
selected. In Table 1, the composition of different formulation 
of aceclofenac fast dissolving tablets is shown in which 
superdisintegrants were selected at 2 levels i.e., lower and 
higher. For starch xanthate (A), the lower level i.e., 5% 
concentration and upper level i.e., 10% concentration. For 
sodium starch glycolate (B) and croscarmellose sodium(C), 
the lower level is 0 concentration and higher level i.e., 5% 
concentration. For uniformity in particle size each ingredient 
was flown through # 100 mesh sized screen before mixing. 
Starch xanthate, sodium starch glycolate, croscarmellose 
sodium, lactose and microcrystalline cellulose were 
accurately weighed mixed using mortar and pestle, and then 
aceclofenac was added. Finally, talc and magnesium stearate 
were administered to the powder mixture. Then the, mixed 
blend was compressed by using eight station rotator press 
Karnawathi Machineries Pvt, Ltd., Ahmedabad, India. 
 
Table: 1: Formulae of aceclofenac fast dissolving tablets employing starch xanthate prepared by direct compression 
method involving lactose as a diluent.  
Ingredients    FL1 FL2 FL3 FL4 FL5 FL6 FL7 FL8 
Aceclofenac 100 100 100 100 100 100 100 100 
Starch xanthate 25 50 25 50 25 50 25 50 
Sodium starch glycolate --- --- 25 25 --- --- 25 25 
Croscarmellose sodium --- --- --- --- 25 25 25 25 
Lactose 155 130 130 105 130 105 105 80 
Micro crystalline cellulose 200 200 200 200 200 200 200 200 
Talc 10 10 10 10 10 10 10 10 
Magnesium sterate 10 10 10 10 10 10 10 10 
Total 500 500 500 500 500 500 500 500 
 
 
Evaluation of aceclofenac fast dissolving tablets: 
Hardness test  
Hardness indicates the ability of a tablet to withstand 
mechanical shocks while handling. The hardness of the tablet 
was calculated using Monsanto hardness tester and 
expressed in kg/cm² 10.  
Uniformity of weight: 
Weight variation test was performed with 20 tablets. It is the 
individual variation of tablet weighed from the average 
weight of 20 tablets. 
Friability:  
The friability of tablets was measured using a Roche 
fribilator. Tablets were rotated at 25 rpm for 4 minutes or up 
to 100 revolutions. The tablets were then reweighed after 
removal of fines and the percentage of weight loss was 
calculated. 
F  
Drug content uniformity:  
For content uniformity, ten tablets were weighed and 
powdered a quantity of powder equivalent to 10mg of 
aceclofenac, which was extracted into 7.4 phosphate buffer 
and filtered. The aceclofenac content was calculated by 
measuring the absorbance spectrophotometrically at 274 nm 
after appropriate dilution with 7.4 phosphate buffer. The 
drug content was determined as an average of three 
determinations 11. 
Wetting time: 
The wetting time of tablets was calculated using a very 
simple procedure five circular tissue papers of 10 cm 
diameter were placed in a petri dish with a 10 cm diameter. 
Ten ml of water containing a water soluble dye (amaranth) 
was added to the petri dish. A tablet was carefully placed on 
the tissue paper. Time required for water to reach the upper 
surface of the tablet was recorded as wetting time 12, 13.   
Water absorption ratio: 
 A piece of tissue paper folded twice in a small petri dish 
containing 6 ml of water. A tablet was put in the tissue paper 
allowed to completely wet. The wetted tablet was then 
weighed. Water absorption ration R was determined using 
following equation. 
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Where, 
Wx = weight of tablet after water absorption. 
Wy = weight of tablet before water absorption. 
In – vitro disintegration time: 
Disintegration time for FDTs was determined using USP 
disintegration apparatus 0.1 N HCl buffer. The volume of 
medium was 900 ml and temperature was 37 ± 0.20C. The 
time in second taken for complete disintegration of the tablet 
with no palatable mass remaining in the apparatus was 
calculated 14. 
In-vitro dissolution studies:  
The in- vitro dissolution rate study  of aceclofenac fast 
dissolving tablets were performed using 8 stage dissolution 
test apparatus ( Electrolab TDT-08L) fitted with paddles (50 
rpm) at 37 ± 0.50C, using 7.4 phosphate buffer (900 ml) as a 
dissolution media. At the predetermined time intervals, 5 ml 
samples were withdrawn, filtered through 0.45µ membrane 
filter, diluted and assayed at 274 nm using a Analytical 
technology T360 UV/Visible Double beam 
spectrophotometer. Cumulative percentage release was 
calculated using standard absorbance from the calibration 
curve. All the dissolution experiments were conducted in 
triplicate (n = 3). 
 
 
RESULTS AND DISCUSSION 
The starch xanthate prepared was found to be fine, free 
flowing slightly crystalline powder. The physical and 
micromeritic properties of the starch xanthate are 
summarized in table 2. It was insoluble in aqueous solvents 
and insoluble in organic solvents tested (methanol, 
petroleum ether, dichloromethane, and chloroform) the pH 
of 0.1% aqueous dispersion was 6.196. 
Starch xanthate exhibited good swelling in water. The 
swelling index was 50% all micrometric properties indicated 
good flow and compressibility needed for solid dosage from 
manufacturing. The density of starch xanthate was found to 
be 0.9848 g/cc. The angle of repose and compressibility 
index showed good flow properties of starch xanthate. The 
FTIR spectrum of potato starch and starch xanthate is shown 
in Fig: 1 and 2. The presence of peaks absorption at 1634.10 
cm-1 characteristic peak of ester, so from FTIR studies it was 
concluded that starch xanthate (ester) was formed when 
starch was allowed to react with formic acid. The X-ray 
diffraction pattern (Fig: 3) of starch xanthate showed 
characteristic peaks, which indicates that the structure is 
slightly crystalline. The disappearance of pink color in the 
ester test confirmed the presence of ester, i.e., starch 
xanthate. As the starch xanthate was slightly crystalline 
powder and it had got all the characteristic of 
superdisintegrants it was concluded that starch xanthate can 
be used as novel superdisintegrant in the formulation of fast 
dissolving tablets. 
 
Table: 2: Physical and micromeritic properties of the starch xanthate prepared 
Parameters Observation 
Solubility Insoluble in all aqueous and organic solvents tested 
pH(1% w/v aqueous 
dispersion) 
6.194 
Melting point Charred at 2180 C 
Viscosity(1% w/v aqueous 
dispersion) 
1.016 cps 
Swelling index 50% 
Gelling property 
No gelling and the swollen particles of starch xanthate separated from water. Where 
as in the case of starch, it was gelatinized and formed gel. 
Particle Size 80 µm (100 mesh) 
Density 0.9848 g/cc 
Bulk density 0.625 g/cc 
Angle of repose 12.40 
Compressibility index 32.5% 
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Figure 1: Fourier transform infrared spectra of potato starch. 
 
Figure 2: Fourier transform infrared spectra of starch xanthate 
 
Figure 3: X-Ray diffraction pattern of starch xanthate 
The X-ray diffraction pattern of starch xanthate showed 3 
characteristic peaks, which indicates that structure is slightly 
crystalline.  
The compatibility of starch xanthate with the selected drug 
(Aceclofenac) was evaluated by FTIR studies. The FTIR 
spectra of aceclofenac and aceclofenac – starch xanthate are 
shown in Figs.4 and 5. The characteristic FTIR bands of 
aceclofenac at 1718.78 cm-1 (COOH), and aceclofenac – 
starch xanthate at 1716.17 cm-1(COOH) were all observed in 
the FTIR spectra of both aceclofenac and aceclofenac – starch 
xanthate. These FTIR spectra observations also indicated no 
interaction between starch xanthate and the drug selected. 
Thus the result of FTIR indicated no interaction between the 
selected drug and starch xanthate, the new 
superdisintegrant. Hence, starch xanthate could be used as a 
superdisintegrant in the design of fast dissolving tablets of 
the selected drug. 
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Figure 4: FTIR spectra of aceclofenac  
 
Figure 5: FTIR Spectra of aceclofenac with starch xanthate   
  
Evaluation of tablets 
Hardness 
Hardness of the tablet was in the range of 3.6±0.02 kg/cm2 to 
4.0±0.05 kg/cm2. It indicates good strength with a capability 
to resist physical and pre functionary stress conditions 
during handling. 
Friability 
All the tablets exhibited acceptable friability as none of the 
tested batches showed percentage friability that exceeded 
1%. As per IP, percent friability below 1% is an indication of 
good mechanical resistance of the tablets. Percent friability 
of all batches found in the range of 0.11%-0.15 %. Thus, it 
was resulted that tablets could withstand the pressure, 
mechanical shocks during handling, transportation, storage 
and manufacturing processes. 
Drug content 
Drug content of all the formulation batches was found to be 
between 97.58±0.71 to 99.56±0.57. Hence, it can be 
concluded that all the formulations are having an accurate 
amount of drug distributed uniformly in powder mass and 
followed acceptable limits as per IP [14]. i.e. 85 to 110 % of 
average content table 3. 
Disintegration studies 
In vitro disintegration time was done by the USP dissolution 
apparatus. The disintegration rate has a correlation with 
water absorption capacity of disintegrate and The In vitro 
disintegration time was found between 12 ±0.02 to 76 ± 0.02 
s. The outcomes were tabulated and data demonstrated in 
table 3. It was found that the formulation FL5 will show least 
disintegration time 12s as compare to other formulation. The 
order for a disintegration time in fast dissolving tablet was 
found to be FL5<FL8<FL6<FL7<FL4<FL3<FL1<FL2. The 
order of disintegration time may be due to the interaction 
and main effects of the super disintegrants used in the fast 
dissolving tablets. 
Water absorption ratio and wetting time 
The water absorption ratio was in between 29±0.18-
183±0.27. The wetting time found between 57±0.21-
246±0.15. The outcomes were tabulated and data 
demonstrated in table 3 and Fig. 6 and 6a. It was found that 
the formulation FL5 containing 5 % starch Xanthate, 5% and 
5 % croscarmellose sodium showed less wetting time i.e. 
57±0.21s as compared to other formulations. 
In vitro dissolution studies 
Dissolution rate depends on the wetting time of the 
disintegrant, among all the formulations FL5 has less wetting 
time and has greater dissolution rate and then this is the 
other conformance test for correct selection of desirable. In 
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vitro dissolution studies of all the formulation were done and 
depicted in fig. 7 and 7a. Log Percent drug undissolved 
studies of all the formulation were done and depicted in fig. 8 
and 8a. In all formulations FL5 formulation was selected as 
the promising formulation containing 5 % starch xanthate, 
and 5 % croscarmellose  sodium with 99.28% release in 10 
min which may be due to the interaction effect between the 
two super disintegrants i.e., starch xanthate, and 
croscarmellose sodium at a concentration of 5 % each. The 
dissolution parameters of the formulation from (FL1–FL8) 
which were made by direct compression method were 
shown in the table 4. In all these cases the PD10 (percent 
dissolved in 10 minute) was more in FL5 which consists at 5 
% starch xanthate, and 5 % croscarmellose sodium. The 
same was in the case of DE5 % (dissolution efficiency in 10 
min). The PD10 & DE5 % revels that starch xanthate was 
effective at 5%, along with 5 % croscarmellose sodium when 
the formulations were made by direct compression using 
these superdisintegrants. From the results, it was concluded 
that starch xanthate (new super disintegrant) could be used 
as a super disintegrant in the formulation of fast dissolving 
tablets of aceclofenac. To evaluate the individual and 
combined effects of the three factors involved, fast dissolving 
tablets were formulated employing selected combinations of 
the factors as per 23-factorial design. ANOVA of fast 
disintegrating times (Table 6) indicated that the individual 
effects of starch xanthate (A), sodium starch glycolate (B) 
and croscarmellose sodium (C) as well as the combined 
effects of AB, AC, BC and ABC factors were significant on 
disintegration time and dissolution efficiency in 5 min of 
aceclofenac fast dissolving tablets. ANOVA of dissolution 
efficiency in 10 min (Table 6) indicated that the individual 
effects as well as combined effects of the three factors (i.e., 
starch xanthate, sodium starch glycolate and crosscarmellose 
sodium) were all significant (p<0.05). The ANOVA results 
thus indicated that the three factors have significantly 
influence on the disintegration time and dissolution 
efficiency in 5 min. 
Fast dissolving tablets formulated employing starch xanthate 
(5%) and croscarmellose sodium (5%) as superdisintegrants 
exhibited in disintegration and dissolution efficiency in 10 
min. Formulation 5 gave release of 99.28% in 10 min 
fulfilling the official specification, based on disintegration 
time and dissolution efficiency in 10 min. Formulation FL5 is 
considered as a good fast dissolving tablet formulations of 
aceclofenac which was found to better than the aceclofenac 
fast dissolving tablets formulated by Manohara P et al 15. 
 
Table 3: Physical properties: hardness, friability drug content of aceclofenac fast dissolving tablets prepared by direct 
compression method involving lactose as a diluent 
Formulation 
Hardness 
(kg/cm2)n± S.D 
Friability  
(%)n± S.D 
Drug Content 
mg/tab) n± S.D 
Disintegration 
Time (sec) n± S.D 
Water Absorption 
Ratio (%) n± S.D 
FL1 3.9 ± 0.01 0.12 ± 0.013 97.58 ± 0.71 76± 0.02 50 ± 0.12 
FL2 3.6 ± 0.02 0.13 ± 0.015 98.10 ± 0.79 93 ± 0.03 29 ± 0.18 
FL3 4.0 ± 0.01 0.14 ± 0.012 99.45 ± 0.63 61 ±0. 02 100 ± 0.16 
FL4 3.8 ± 0.04 0.12 ± 0.014 98.56 ± 0.55 48±0. 02 131 ± 0.15 
FL5 3.7 ± 0.03 0.14 ± 0.012 99. 56 ± 0.56 12 ± 0.01 183 ± 0.21 
FL6 3.9 ± 0.01 0.15 ± 0.012 99.34 ± 0.18 17 ± 0.02 135 ± 0.12 
FL7 3.7 ± 0.02 0.14 ± 0.014 99.23 ± 0.57 21 ±0. 01 173 ± 0.15 
FL8 4.0 ± 0.05 0.12 ± 0.013 99.17 ± 0.11 15 ± 0.02 176 ± 0.27 
 
 
FL-1 of Aceclofenac fast dissolving tablets   FL-2 of Aceclofenac fast dissolving tablet 
                            
At Time = 0 sec              At Time = 76 sec                                    At Time = 0 sec                 At Time  = 107 sec 
FL-3 of Aceclofenac fast dissolving tablets    FL-4 of Aceclofenac fast dissolving tablet               
                               
         At Time = 0 sec              At Time = 68 sec                                   At Time = 0 sec                 At Time = 64 sec 
Figure 6: Aceclofenac fast dissolving tablets prepared employing starch xanthate involving lactose as diluent. 
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FL-5 of Aceclofenac fast dissolving tablets       FL-6 of Aceclofenac fast dissolving tablet                                  
                              
At Time = 0 sec                At Time = 45 sec                                         At Time = 0 sec                 At Time = 83 sec 
FL-7 of Aceclofenac fast dissolving tablets       FL-8 of Aceclofenac fast dissolving tablet 
                           
At Time = 0 sec                At Time = 246 sec                                         At Time = 0 sec                  At Time = 57 sec 
Figure 6 a: Aceclofenac fast dissolving tablets prepared employing starch xanthate involving lactose as diluent. 
 
 
Figure 7: Dissolution profiles of aceclofenac fast 
dissolving tablets prepared employing starch xanthate 
involving lactose as a diluent (FL1- FL4) 
 
Figure 7a: Dissolution profiles of aceclofenac fast 
dissolving tablets prepared employing starch xanthate 
involving lactose as a diluent (FL5- FL8) 
 
Figure 8: Time Vs Log Percent drug undissolved plots for 
aceclofenac fast dissolving tablets prepared employing 
starch xanthate involving lactose as a diluent (FL1- FL4) 
 
Figure 8a: Time Vs Log Percent drug undissolved plots 
for aceclofenac fast dissolving tablets prepared 
employing starch xanthate involving lactose as a diluent 
(FL5- FL8)
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Table 5: dissolution parameters of aceclofenac fast dissolving tablets formulated employing starch xanthate and other 
known superdisintegrants prepared by direct compression method involving lactose as a diluent  
Time(mins) FL-1 FL-2 FL-3 FL-4 FL-5 FL-6 FL-7 FL-8 
PD10 73.33  91.55  49.54  44.78  99.28  15.56  64.09  58.77  
DE5 % 18.1 25.2 20.7 16.4 48.6 7.8 17.4 21.8 
No of folds increase in DE5 % ---- 1.39 1.14 0.90 2.68 0.43 0.96 1.20 
K1 (min-1) 0.10 0.02 0.07 0.02 0.01 0.01 0.02 0.09 
 
Table 6: ANOVA of dissolution efficiency in 10 min of aceclofenac fast dissolving tablets formulated employing starch 
xanthate involving lactose as a diluent 
Source of Variation d.f S.S M.S.S 
Variance 
ratio 
Result 
Replicates 2 2.90 1.45 2.36 P ˃ 0.05 
Treatments 7 2245.76 320.82 524.2 P ˂ 0.05 
Starch xanthate (5%) 1 7729.27 7729.27 12629.52 P ˂ 0.05 
Starch xanthate (10%) 1 182.05 182.05 297.46 P ˂ 0.05 
Starch xanthate (5%) X Sodium starch glycolate (5%) 1 63.05 63.05 103.02 P ˂ 0.05 
Starch xanthate (10%) X Sodium starch glycolate (5%) 1 103.75 103.75 40.19 P ˂ 0.05 
Starch xanthate (5%) X Croscarmellose sodium (5%) 1 2.87 2.87 4.68 P ˂ 0.05 
Starch xanthate (10%) X Croscarmellose sodium (5%) 1 1177.40 1177.40 1923.85 P ˂ 0.05 
Starch xanthate (5%) X Sodium starch glycolate (5%) X Croscarmellose 
sodium (5%) 
1 63.05 63.05 103.02 P ˂ 0.05 
Starch xanthate (10%) X Sodium starch glycolate (5%) X Croscarmellose 
sodium (5%) 
1 247.68 247.68 404.70 P ˂ 0.05 
Error 14 2.90 1.45 2.36 P ˃ 0.05 
Total 23 2245.76 320.82 524.2 P ˂ 0.05 
P<0.05 indicate significance; p>0.05 indicate non-significance d.f – Degree of Freedom * S.S – Sum of Square * M.S.S – Mean Sum 
of Squares  
CONCLUSION 
Starch xanthate is an efficient superdisintegrant for fast 
dissolving tablets. The disintegration and dissolution 
efficiency of the fast dissolving tablets of aceclofenac was 
good and depended on the concentration of 
superdisintegrant employed i.e., starch xanthate, sodium 
starch glycolate, croscarmellose sodium. The formulated fast 
dissolving tablets of aceclofenac exhibited good dissolution 
efficiency in 10 min which can be used for the fast 
therapeutic action of aceclofenac. Overall, Starch xanthate 
was found to be a superdisintegrant which enhanced the 
dissolution efficiency when combined with croscarmellose 
sodium, with the aceclofenac and hence it could be used in 
the formulation of fast dissolving tablets to provide 
immediate release of the contained drug within 10minutes. 
Abbreviations 
FTIR - Fourier transform infrared spectra  
DSC - Differential scanning calorimetry 
ANOVA – Analysis of variance  
PD5-Percent dissolved in 5 minutes 
DE5%- Dissolution efficiency in 5 minutes 
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